2 ML casimersen 50 MG/ML Injection [Amondys 45]
- RxCUI
- 2480105
- RxNorm name
- 2 ML casimersen 50 MG/ML Injection [Amondys 45]
- Display name
- 2 ML casimersen 50 MG/ML Injection [Amondys 45]
- Full name
- 2 ML casimersen 50 MG/ML Injection [Amondys 45]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:26
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMONDYS 45 | CASIMERSEN | Sarepta Therapeutics, Inc. | e9e5fd44-eeda-4580-bba1-a734828bbcc3 | 2026-01-09 | Warnings, Adverse reactions | 2480105 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e9e5fd44-eeda-4580-bba1-a734828bbcc3 | Amondys 45 100 MG in 2 ML Injection [PSN] · 2 ML casimersen 50 MG/ML Injection [Amondys 45] [SBD] · 2 ML Amondys 45 50 MG/ML Injection [SY] · Amondys 45 100 MG per 2 ML Injection [SY] · Amondys 45 50 MG/ML per 2 ML Injection [SY] | 5 | 11 | These highlights do not include all the information needed to use AMONDYS 45 ® safely and effectively. See full prescribing information for AMONDYS 45. AMONDYS 45 (casimersen) injection, for intravenous use Initial U.S. Approval: 2021 | 20260109 |